Michael Saddekni, M.D.

Michael has over 11 years of experience in medical and clinical research within various therapeutic areas, including as a principal Investigator in Rheumatology. He led the Filgotinib launch in RA at Gilead Science and was Regional Rheumatology lead at The Permanente Medical Group, CA.

Michael completed his Post-Doctoral Fellowship Training in Rheumatology at The University of Alabama, Birmingham (US) and Master of Science degree in Rheumatology and Immunology at the University of South Wales (UK). He completed his Rheumatology postgraduate studies at the University of South Wales (UK). Michael is also Medical Affairs Board Certified – Accreditation Council for Medical Affairs (US).